A citation-based method for searching scientific literature

Bjoern Chapuy, Margaretha G M Roemer, Chip Stewart, Yuxiang Tan, Ryan P Abo, Liye Zhang, Andrew J Dunford, David M Meredith, Aaron R Thorner, Ekaterina S Jordanova, Gang Liu, Friedrich Feuerhake, Matthew D Ducar, Gerald Illerhaus, Daniel Gusenleitner, Erica A Linden, Heather H Sun, Heather Homer, Miyuki Aono, Geraldine S Pinkus, Azra H Ligon, Keith L Ligon, Judith A Ferry, Gordon J Freeman, Paul van Hummelen, Todd R Golub, Gad Getz, Scott J Rodig, Daphne de Jong, Stefano Monti, Margaret A Shipp. Blood 2016
Times Cited: 305



Alexander M Lesokhin, Stephen M Ansell, Philippe Armand, Emma C Scott, Ahmad Halwani, Martin Gutierrez, Michael M Millenson, Adam D Cohen, Stephen J Schuster, Daniel Lebovic, Madhav Dhodapkar, David Avigan, Bjoern Chapuy, Azra H Ligon, Gordon J Freeman, Scott J Rodig, Deepika Cattry, Lili Zhu, Joseph F Grosso, M Brigid Bradley Garelik, Margaret A Shipp, Ivan Borrello, John Timmerman. J Clin Oncol 2016
Times Cited: 687




List of shared articles



Times cited

Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies.
Inna Serganova, Sanjukta Chakraborty, Samuel Yamshon, Yusuke Isshiki, Ryan Bucktrout, Ari Melnick, Wendy Béguelin, Roberta Zappasodi. Front Cell Dev Biol 2022
2

Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL.
Tingting Zhang, Hengqi Liu, Lei Jiao, Zhenzhen Zhang, Jin He, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Wenchen Gong,[...]. J Immunother Cancer 2022
2

Immune-Checkpoint Inhibitors in B-Cell Lymphoma.
Marc Armengol, Juliana Carvalho Santos, Miranda Fernández-Serrano, Núria Profitós-Pelejà, Marcelo Lima Ribeiro, Gaël Roué. Cancers (Basel) 2021
12

Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma.
Clifford M Csizmar, Stephen M Ansell. Int J Mol Sci 2021
4

Immunity reloaded: Deconstruction of the PD-1 axis in B cell lymphomas.
Karolina Bednarska, Karthik Nath, William Nicol, Maher K Gandhi. Blood Rev 2021
1

PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell Lymphoma.
Joshua W D Tobin, Karolina Bednarska, Ashlea Campbell, Colm Keane. Cells 2021
5

Immune checkpoint inhibitors in lymphoma: challenges and opportunities.
Haris Hatic, Devi Sampat, Gaurav Goyal. Ann Transl Med 2021
8

Immune checkpoint inhibition for the treatment of cancers: An update and critical review of ongoing clinical trials.
Hamidreza Akhbariyoon, Yasaman Azizpour, Marjan Fakhrizadeh Esfahani, Maryam Sadat Mirbagheri Firoozabad, Mehrdad Rabiee Rad, Kiarash Sadeghian Esfahani, Neda Khoshavi, Negin Karimi, Asal Shirinisaz, Fatemeh Abedi,[...]. Clin Immunol 2021
10

The immune landscape and response to immune checkpoint blockade therapy in lymphoma.
Justin Kline, James Godfrey, Stephen M Ansell. Blood 2020
74